ProPhase Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

ProPhase General Information


Provider of specialty services in clinical trials. The company's services help to optimize the selection, use and analysis of behavioral endpoints to mitigate trial risk and maximize the likelihood of study success enabling medical enterprises to transform measurement science in clinical trials and improve outcomes for all stakeholders.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 3 Park Avenue
  • 28th & 37th Floor
  • New York, NY 10016
  • United States
+1 (212) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProPhase Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProPhase‘s full profile, request access.

Request a free trial

ProPhase Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Clintara Private Equity-Backed Boston, MA 00 000000000000
00000000 Formerly VC-backed Melbourne, Australia 000 000.00 000000000 000.00
0000000000 Private Equity-Backed Princeton, NJ 0000 000.00 000000000000 000.00
00000 000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000

ProPhase Executive Team (2)

Name Title Board Seat Contact Info
Sofija Jovic Ph.D Chief Executive Officer, Principal & Managing Board Member
Mark Opler Ph.D Founder, Principal & Chief Scientific Officer

ProPhase Board Members (1)

Name Representing Role Since
000000 00000 00.0 ProPhase Chief Executive Officer, Principal & Managing Board Member 000 0000